Matrix metalloproteinase inhibitors

Details for Australian Patent Application No. 2007287230 (hide)

Owner Ranbaxy Laboratories Limited

Inventors Dastidar, Sunanda G.; Srivastava, Punit Kumar; Khera, Manoj Kumar; Rauf, Abdul Rehman Abdul; Reddy, Ranadheer; Sattigeri, Viswajanani J.; Joseph, Sony; Musib, Arpita; Palle, Venkata P.; Tiwari, Manoj Kumar; Soni, Ajay

Agent Callinan

Pub. Number AU-A-2007287230

PCT Pub. Number WO2008/023336

Priority 1880/DEL/2006 22.08.06 IN

Filing date 21 August 2007

Wipo publication date 28 February 2008

International Classifications

A61K 31/4035 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 209/48 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/023336 Priority application(s): WO2008/023336

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007287263-Lalpha-hydroxy-2- (3 ' - hydroxypropylidene) -19-norvitamin D compounds with a 1,1-dimethylpropyl side chain

2007287222-System and method for indicating track relationships in media files